Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Serological cross reactivity between polyomavirus capsids.

Viscidi RP, Clayman B.

Adv Exp Med Biol. 2006;577:73-84. Review.

PMID:
16626028
2.

Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.

Viscidi RP, Snyder B, Cu-Uvin S, Hogan JW, Clayman B, Klein RS, Sobel J, Shah KV.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):283-8.

3.

Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica.

Wang SS, Schiffman M, Herrero R, Carreon J, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Clayman B, Burk RD, Viscidi RP.

Br J Cancer. 2004 Oct 4;91(7):1269-74.

4.

Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.

Viscidi RP, Schiffman M, Hildesheim A, Herrero R, Castle PE, Bratti MC, Rodriguez AC, Sherman ME, Wang S, Clayman B, Burk RD.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):324-7.

5.

Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.

Viscidi RP, Ahdieh-Grant L, Schneider MF, Clayman B, Massad LS, Anastos KM, Burk RD, Minkoff H, Palefsky J, Levine A, Strickler H.

J Infect Dis. 2003 Dec 15;188(12):1834-44. Epub 2003 Dec 5.

PMID:
14673762
6.

Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica.

Wang SS, Schiffman M, Shields TS, Herrero R, Hildesheim A, Bratti MC, Sherman ME, Rodriguez AC, Castle PE, Morales J, Alfaro M, Wright T, Chen S, Clayman B, Burk RD, Viscidi RP.

Br J Cancer. 2003 Oct 6;89(7):1248-54.

7.

Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.

Viscidi RP, Rollison DE, Viscidi E, Clayman B, Rubalcaba E, Daniel R, Major EO, Shah KV.

Clin Diagn Lab Immunol. 2003 Mar;10(2):278-85.

8.

Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.

Viscidi RP, Ahdieh-Grant L, Clayman B, Fox K, Massad LS, Cu-Uvin S, Shah KV, Anastos KM, Squires KE, Duerr A, Jamieson DJ, Burk RD, Klein RS, Minkoff H, Palefsky J, Strickler H, Schuman P, Piessens E, Miotti P.

J Infect Dis. 2003 Jan 15;187(2):194-205. Epub 2003 Jan 6.

PMID:
12552444
9.

Phonon screening in high-temperature superconductors

Homes CC, McConnell AW, Clayman BP, Bonn DA, Liang R, Hardy WN, Inoue M, Negishi H, Fournier P, Greene RL.

Phys Rev Lett. 2000 Jun 5;84(23):5391-4.

PMID:
10990951
10.

Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.

Sun Y, Eluf-Neto J, Bosch FX, Muñoz N, Walboomers JM, Meijer CJ, Shah KV, Clayman B, Viscidi RP.

Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):935-40.

11.

Adeno-associated virus and development of cervical neoplasia.

Strickler HD, Viscidi R, Escoffery C, Rattray C, Kotloff KL, Goldberg J, Manns A, Rabkin C, Daniel R, Hanchard B, Brown C, Hutchinson M, Zanizer D, Palefsky J, Burk RD, Cranston B, Clayman B, Shah KV.

J Med Virol. 1999 Sep;59(1):60-5.

PMID:
10440809
12.

A survey of human papillomavirus 16 antibodies in patients with epithelial cancers.

Strickler HD, Schiffman MH, Shah KV, Rabkin CS, Schiller JT, Wacholder S, Clayman B, Viscidi RP.

Eur J Cancer Prev. 1998 Aug;7(4):305-13.

PMID:
9806119
14.

Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.

Viscidi RP, Kotloff KL, Clayman B, Russ K, Shapiro S, Shah KV.

Clin Diagn Lab Immunol. 1997 Mar;4(2):122-6.

15.

Electric field dependence of pocket and nonpocket impurity gap modes in KI and the establishment of Ag+ quadrupolar deformability.

Rosenberg A, Sandusky KW, Clayman BP, Page JB, Sievers AJ.

Phys Rev B Condens Matter. 1996 Mar 1;53(10):6076-6103. No abstract available.

PMID:
9982006
16.

Effect of isotopic disorder on the Fu modes in crystalline C60.

Homes CC, Horoyski PJ, Thewalt ML, Clayman BP, Anthony TR.

Phys Rev B Condens Matter. 1995 Dec 15;52(23):16892-16900. No abstract available.

PMID:
9981097
17.

Softening of a reststrahlen band in CuO near the Néel transition.

Homes CC, Ziaei M, Clayman BP, Irwin JC, Franck JP.

Phys Rev B Condens Matter. 1995 Feb 1;51(5):3140-3150. No abstract available.

PMID:
9979099
18.

Infrared study of RBa2Cu4O8 (R=Y,Er,Dy,Gd).

Buckley RG, Ziaei M, Clayman BP, Haines EM.

Phys Rev B Condens Matter. 1994 May 1;49(18):13175-13183. No abstract available.

PMID:
10010235
19.

Anomalous splitting of the F1u(-->3Fu) vibrations in single-crystal C60 below the orientational-ordering transition.

Homes CC, Horoyski PJ, Thewalt ML, Clayman BP.

Phys Rev B Condens Matter. 1994 Mar 1;49(10):7052-7055. No abstract available.

PMID:
10009437
20.

Antibodies to recombinant gp160 in mucosal secretions and sera of persons infected with HIV-1 and seronegative vaccine recipients.

Funkhouser A, Clements ML, Slome S, Clayman B, Viscidi R.

AIDS Res Hum Retroviruses. 1993 Jul;9(7):627-32.

PMID:
8369168
21.

Infrared study of Ca-substituted YBa2Cu4O8 high-Tc superconductors.

Ziaei ME, Clayman BP, Buckley RG, Haines EM.

Phys Rev B Condens Matter. 1992 Nov 1;46(17):10997-11003. No abstract available.

PMID:
10002962
22.

Wedge-shaped polyethylene far-infrared windows.

Ziaei ME, Clayman BP.

Appl Opt. 1992 Feb 1;31(4):437-8. doi: 10.1364/AO.31.000437. No abstract available.

PMID:
20720630
23.

Humoral immune responses to gag and env proteins from human immunodeficiency virus type 1 in hemophiliac patients.

Kinney JS, Conway JH, Hilgartner MW, Clayman B, Mayur K, Yolken RH, Viscidi RP.

Am J Hematol. 1991 Jan;36(1):35-41.

PMID:
1984680
24.

Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network.

Viscidi R, Ellerbeck E, Garrison L, Midthun K, Clements ML, Clayman B, Fernie B, Smith G.

AIDS Res Hum Retroviruses. 1990 Nov;6(11):1251-6.

PMID:
1706607
25.

Energy gaps of Nd1.85Ce0.15CuO4-y and Nd1.85Th0.15CuO4-y determined by far-infrared spectroscopy.

Wang SH, Song Q, Clayman BP, Peng JL, Zhang L, Shelton RN.

Phys Rev Lett. 1990 Feb 26;64(9):1067-1070. No abstract available.

PMID:
10042154
26.

Effective charge and ionicity in Cd1-xMnxTe.

Perkowitz S, Sudharsanan R, Wrobel JM, Clayman BP, Becla P.

Phys Rev B Condens Matter. 1988 Sep 15;38(8):5565-5567. No abstract available.

PMID:
9946997
27.

Temperature dependence of the far-infrared reflectivity spectrum of the high-Tc superconductor YBa2Cu3O7-y.

Wrobel JM, Wang S, Gygax S, Clayman BP, Peterson LK.

Phys Rev B Condens Matter. 1987 Aug 1;36(4):2368-2370. No abstract available.

PMID:
9943104
28.

Use of polypropylene film for infrared cryogenic Windows.

Labrie D, Booth IJ, Thewalt ML, Clayman BP.

Appl Opt. 1986 Jan 15;25(2):171-2. doi: 10.1364/AO.25.000171. No abstract available.

PMID:
20445681
29.

Far-infrared absorption spectra of the ground-state-to- excited-state transitions of excitons bound to the double acceptors Be and Zn in Ge.

Labrie D, Thewalt ML, Clayman BP, Timusk T.

Phys Rev B Condens Matter. 1985 Oct 15;32(8):5514-5516. No abstract available.

PMID:
9937789
30.

Observation of a large ground-state splitting in the infrared absorption spectrum of Zn in Ge.

Thewalt ML, Clayman BP, Labrie D.

Phys Rev B Condens Matter. 1985 Aug 15;32(4):2663-2666. No abstract available.

PMID:
9937356
31.

Reflectivity measurements on hot reactive liquids using a FIR laser.

Johnston SF, Clayman BP.

Appl Opt. 1980 Sep 15;19(18):3118-20. doi: 10.1364/AO.19.003118.

PMID:
20234573
32.

Far infrared absorption of the water-lecithin system.

Colbow K, Clayman BP.

Biochim Biophys Acta. 1973 Sep 27;323(1):1-6. No abstract available.

PMID:
4751244

Supplemental Content

Loading ...
Support Center